Co-crystals comprising VX-950 and pharmaceutical compositions comprising the same

Details for Australian Patent Application No. 2007217355 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Connelly, Patrick R.; Morissette, Sherry; Tauber, Michael

Agent Spruson & Ferguson

Pub. Number AU-B-2007217355

PCT Pub. Number WO2007/098270

Priority 60/777,221 27.02.06 US

Filing date 27 February 2007

Wipo publication date 30 August 2007

Acceptance publication date 21 June 2012

International Classifications

C07D 403/02 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/497

A61K 31/60 - Salicylic acid

A61P 31/12 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

16 October 2008 PCT application entered the National Phase

  PCT publication WO2007/098270 Priority application(s): WO2007/098270

27 November 2008 Amendment Made

  The nature of the amendment is: Amend the co-inventor name from Morisette, Sherry to Morissette, Sherry

21 June 2012 Application Accepted

  Published as AU-B-2007217355

18 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007217363-Inhibitors of PAI-1 for treatment of muscular conditions

2007217354-Dual flush activation